Obesity among children and adolescents is a growing public health problem. The aim of the present paper is to identify potential
determinants of obesity and risk groups among 3- to 17-year old children and adolescents to provide a basis for effective
prevention strategies. 相似文献
Extended-spectrum β-lactamases (ESBLs), mainly of the CTX-M family, have been associated with Escherichia coli strains of animal origin in Europe. An in vivo experiment was performed to study the effects of veterinary β-lactam drugs on the selection and persistence of ESBL-producing E. coli in the intestinal flora of pigs. Twenty pigs were randomly allocated into three treatment groups and one control group. All pigs were inoculated intragastrically with 1010 CFU of a nalidixic acid (NAL)-resistant mutant derived from a CTX-M-1-producing E. coli strain of pig origin. Treatment with amoxicillin, ceftiofur, or cefquinome according to the instructions on the product label was initiated immediately after bacterial inoculation. Feces were collected from the rectum before inoculation and on days 4, 8, 15, 22, and 25 after the start of treatment. The total and resistant coliforms were counted on MacConkey agar with and without cefotaxime (CTX). Furthermore, MacConkey agar with CTX and NAL was used to count the number of CFU of the inoculated strain. Significantly higher counts of CTX-resistant coliforms were observed in the three treatment groups than in the control group for up to 22 days after the discontinuation of treatment. Ceftiofur and cefquinome exerted larger selective effects than amoxicillin, and the effects persisted beyond the withdrawal times recommended for these cephalosporins. The inoculated strain was detected in only nine animals on day 25. The increase in the number of CTX-resistant coliforms was mainly due to the proliferation of indigenous CTX-M-producing strains and the possible emergence of strains that acquired CTX-M genes by horizontal transfer. The study provides evidence that the cephalosporins used in pig production select for CTX-M-producing E. coli strains. Their use in animals should be carefully considered in view of the critical importance of cephalosporins and the zoonotic potential of ESBL-producing bacteria. 相似文献
Association between calcium intake and premature mortality in the general population has been well studied, but little is known about the association among specific populations. The authors aim to evaluate the association among people with hypertension and to provide a proper reference range of dietary calcium intake. This prospective cohort study included 8534 US adults with hypertension from National Health and Nutrition Examination Survey cycles 2003–2014. Dietary calcium intakes were self-reported and mortality status was ascertained by National Death Index records. During a median follow-up of 5.9 years, 1357 death occurred. Compared with participants of dietary calcium intake in quintile 1, participants in quintiles 2 and 4 had a 27% (HR: 0.73, 95% CI: 0.60–0.89) and a 29% lower risk (HR: 0.71, 95% CI: 0.57–0.88) of all-cause mortality respectively. The authors also observed a 34% lower risk (HR: 0.66, 95% CI: 0.45–0.97) of CVD death among participants in quintile 3 and a 37% lower risk (HR: 0.63, 95% CI: 0.40–0.99) of cancer-related death in participants in quintile 4 respectively. Restricted cubic spline (RCS) regression revealed a consistent protective effect of dietary calcium in participants with a daily intake of over 1000 mg, but a daily intake over 1200 mg fails to show further protective effect. Our findings suggest that elevated dietary calcium was associated with lower mortality risk from all-causes, cardiovascular disease (CVD) and cancer, and supplying sufficient dietary calcium intake, between 1000 and 1200 mg per day, in people with hypertension may be considered cost-effective to decrease risk of premature death. 相似文献
Eight patients (pts; 2 female, 58 +/- 12 yrs) with paroxysmal atrial fibrillation (AF) (duration 39 +/- 20 months) underwent AF surgery, with concomitant myocardial revascularization in 2 pts and myomectomy in 1 (HOCM). AF was idiopathic in the remaining 5 pts. AF surgery consisted of bilateral isolation of the pulmonary veins (PV) using radiofrequency (RF) energy applied epicardially by a heptapolar catheter (Thermaline) in 5 pts and by a new system (Atricure) in 3 pts. For the former, each set of 7 simultaneous applications aimed at a maximum duration of 2 + 2 min., preset temperature 80 degrees C and output 150 watts. With the new system, bipolar applications were carried out; energy delivery was controlled by impedance monitoring and applications were ended after abrupt, sustained elevation of impedance. Epicardial bipolar voltage mapping (CARTO) was performed before and after each RF procedure. Using the navigator catheter, points were recorded at the insertion of each PV and at the non-isolated left atrial posterior wall. The amplitude of the local electrograms (LE) was measured before and after RF applications. If the LE amplitude inside the isolated zone was not 0.1 mV and not reduced by > 80%, a second application was performed. A maximum of 2 epicardial applications were carried out in each pt and if the final result was unsatisfactory, further endocardial applications were performed. RESULTS: Baseline LE amplitudes were > 1 mV in all cases. Successful isolation of right PVs was achieved in 7 pts, after one set of applications in 5 and a second set in 2. Left PV isolation required 2 sets of epicardial applications in all pts, being successful in only 2; 4 pts (one with associated myomectomy and 3 with idiopathic AF) received endocardial applications. Overall, bilateral PV isolation was achieved in 5 pts. CONCLUSIONS: CARTO bipolar voltage mapping is a fast, simple means for evaluation of epicardial PV isolation. 相似文献
Objective: The authors reviewed efficacy and safety data for ondansetron for preventing postoperative nausea and vomiting (PONV).
Methods: Systematically searched, randomized, controlled trials (obtained through MEDLINE, EMBASE, Biological Abstracts, manufacturer's database, manual searching of journals, and article reference lists) were analyzed. Relevant end points were prevention of early PONV (within 6 h after surgery) and late PONV (within 48 h) and adverse effects. Relative benefit and number-needed-to-treat were calculated. The number-needed-to-treat indicated how many patients had to be exposed to ondansetron to prevent PONV in one of them who would have vomited or been nauseated had he or she received placebo.
Results: Fifty-three trials were found that had data from 7,177 patients receiving 24 different ondansetron regimens and from 5,712 controls receiving placebo or no treatment. Average early and late PONV incidences without ondansetron were 40% and 60%, respectively. There was a dose response for oral and intravenous ondansetron. Best number-needed-to-treat to prevent PONV with the best documented regimens was between 5 and 6. This was achieved with an intravenous dose of 8 mg and an oral dose of 16 mg. Antivomiting efficacy was consistently better than antinausea efficacy. Efficacy in children was poorly documented. Ondansetron significantly increased the risk for elevated liver enzymes (number-needed-to-harm was 31) and headache (number-needed-to-harm was 36). 相似文献